hemotune
hemotune is developping a revolutionary therapeutic blood purification platform.
hemotune has raised €4.7M across 1 funding round from 1 investor, most recently a Series A round in Aug 2020. Based in Zurich, Switzerland; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€4.7M
€4,747,277
Funding rounds
1
Investors
1
distinct backers
Active since
2020-08
latest 2020-08
Funding by year
EUR raised per yearhemotune — funding by year — interactive chart.
Data table
| hemotune — funding by year | |
|---|---|
| 2020 | €4.7M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-08-12 | Series A | €4.7M | OCCIDENT | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData